Macrophages and CD8+ T Cells Mediate the Anti-Tumor Efficacy of Combined CD40 Ligation and Imatinib Therapy in Gastrointestinal Stromal Tumors

Cancer immunology research - United States
doi 10.1158/2326-6066.cir-17-0345
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Optimizing Surgical and Imatinib Therapy for the Treatment of Gastrointestinal Stromal Tumors

Journal of Gastrointestinal Surgery
SurgeryGastroenterology
2013English

CD40 Ligation in the Presence of Self-Reactive CD8 T Cells Leads to Severe Immunopathology

Journal of Immunology
AllergyImmunology
2002English

Update on the Treatment of Gastrointestinal Stromal Tumors (GISTs): Role of Imatinib

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2010English

Gastrointestinal Stromal Tumors Treated With Imatinib Mesylate: Apparent Diffusion Coefficient in the Evaluation of Therapy Response in Patients

Radiology
Nuclear MedicineRadiologyImaging
2011English

Efficacy and Safety of Endoscopic Treatment for Gastrointestinal Stromal Tumors in the Upper Gastrointestinal Tract

Clinical Endoscopy
MedicineNuclear MedicineRadiologyImagingGastroenterology
2020English

The Economic Burden of Gastrointestinal Stromal Tumor (GIST) Recurrence in Patients Who Have Received Adjuvant Imatinib Therapy

Journal of Medical Economics
Health Policy
2014English

CD40 Signaling in CD8+CD40+ T Cells Turns on Contra-T Regulatory Cell Functions

Journal of Immunology
AllergyImmunology
2010English

Neoadjuvant Therapy for Gastrointestinal Stromal Tumor

Translational Gastroenterology and Hepatology
2018English

Imatinib Induced Severe Skin Reactions and Neutropenia in a Patient With Gastrointestinal Stromal Tumor

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy